OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
August 02, 2022
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
July 02, 2022
The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.
July 01, 2022
As we reach further afield in the molecular universe, we encounter new types of problems to resolve.
June 21, 2022
Avid Bioservices has expanded its viral vector development and manufacturing facility with the addition of analytical and process development suites.
May 03, 2022
An increasingly complex development pipeline and industry considerations, such as sustainability, are leading to a greater need for more efficient separation and purification in downstream processing.
May 01, 2022
Some progress has been made, but improvements are needed when harvesting cells for cell therapies.
This article summarizes industry views on PAT in bioprocess-related applications and presents a vision for the biopharmaceutical industry to achieve Industry 4.0.
March 09, 2022
New technologies are treatments are emerging to tackle COVID-19 and its assortment of new variants.
March 03, 2022
Flexible and efficient methods are needed for biopharmaceutical manufacturing.
February 01, 2022
Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.